Literature DB >> 19170198

The management of tics.

David Shprecher1, Roger Kurlan.   

Abstract

A tic is a stereotyped repetitive involuntary movement or sound, frequently preceded by premonitory sensations or urges. Most tic disorders are genetic or idiopathic in nature, possibly due to a developmental failure of inhibitory function within frontal-subcortical circuits modulating volitional movements. Currently available oral medications can reduce the severity of tics, but rarely eliminate them. Botulinum toxin injections can be effective if there are a few particularly disabling motor tics. Deep brain stimulation has been reported to be an effective treatment for the most severe cases, but remains unproven. A comprehensive evaluation accounting for secondary causes, psychosocial factors, and comorbid neuropsychiatric conditions is essential to successful treatment of tic disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19170198      PMCID: PMC2701289          DOI: 10.1002/mds.22378

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  114 in total

1.  Adult-onset tic disorders.

Authors:  Valsamma Eapen; Andrew J Lees; J P W F Lakke; Michael R Trimble; Mary M Robertson
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

2.  Dopamine transporter binding in Gilles de la Tourette syndrome.

Authors:  K R Müller-Vahl; G Berding; T Brücke; H Kolbe; G J Meyer; H Hundeshagen; R Dengler; W H Knapp; H M Emrich
Journal:  J Neurol       Date:  2000-07       Impact factor: 4.849

3.  Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.

Authors:  H S Singer; J Wendlandt; M Krieger; J Giuliano
Journal:  Neurology       Date:  2001-03-13       Impact factor: 9.910

4.  Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial.

Authors:  C Marras; D Andrews; E Sime; A E Lang
Journal:  Neurology       Date:  2001-03-13       Impact factor: 9.910

5.  Repetitive transcranial magnetic stimulation for Tourette syndrome.

Authors:  A Münchau; B R Bloem; K V Thilo; M R Trimble; J C Rothwell; M M Robertson
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

6.  Treatment of ADHD in children with tics: a randomized controlled trial.

Authors: 
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

Review 7.  Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis.

Authors:  J W Mink
Journal:  Pediatr Neurol       Date:  2001-09       Impact factor: 3.372

8.  The behavioral spectrum of tic disorders: a community-based study.

Authors:  R Kurlan; P G Como; B Miller; D Palumbo; C Deeley; E M Andresen; S Eapen; M P McDermott
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

9.  Hallervorden-Spatz syndrome resembling a typical Tourette syndrome.

Authors:  Valentina Scarano; Maria Teresa Pellecchia; Alessandro Filla; Paolo Barone
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

10.  Tourettism and dystonia after subcortical stroke.

Authors:  Carolyn H Kwak; Joseph Jankovic
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

View more
  19 in total

Review 1.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

2.  Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options.

Authors:  Olumide O Oluwabusi; Susan Parke; Paul J Ambrosini
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 3.  The clinical approach to movement disorders.

Authors:  Wilson F Abdo; Bart P C van de Warrenburg; David J Burn; Niall P Quinn; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2010-01       Impact factor: 42.937

4.  Levetiracetam as an alternative therapy for Tourette syndrome.

Authors:  M A Martínez-Granero; A García-Pérez; F Montañes
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

5.  Tourette Syndrome: Bridging the Gap between Genetics and Biology.

Authors:  Petra Richer; Thomas V Fernandez
Journal:  Mol Neuropsychiatry       Date:  2015-09-04

6.  Behavioral Treatments for Tourette Syndrome.

Authors:  Matthew R Capriotti; Michael B Himle; Douglas W Woods
Journal:  J Obsessive Compuls Relat Disord       Date:  2014-04-03       Impact factor: 1.677

Review 7.  Botulinum toxin for motor and phonic tics in Tourette's syndrome.

Authors:  Sanjay Pandey; Prachaya Srivanitchapoom; Richard Kirubakaran; Brian D Berman
Journal:  Cochrane Database Syst Rev       Date:  2018-01-05

8.  Clinical approach to motor stereotypies in autistic children.

Authors:  Ahmad Ghanizadeh
Journal:  Iran J Pediatr       Date:  2010-06       Impact factor: 0.364

9.  Outpatient Treatment of Tic Disorders Among Children and Adults.

Authors:  Joseph L Smith; Sean Gregory; Nicole McBride; Tanya K Murphy; Eric A Storch
Journal:  Mov Disord Clin Pract       Date:  2017-03-11

10.  Fidelity of Delivery and Contextual Factors Influencing Children's Level of Engagement: Process Evaluation of the Online Remote Behavioral Intervention for Tics Trial.

Authors:  Kareem Khan; Chris Hollis; Charlotte L Hall; Elizabeth Murray; E Bethan Davies; Per Andrén; David Mataix-Cols; Tara Murphy; Cris Glazebrook
Journal:  J Med Internet Res       Date:  2021-06-21       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.